Collocation of metformin and dipeptidyl peptidase-4 inhibitor is associated with increased risk of diabetes-related vascular dementia: A single hospital study in Northern Taiwan

References

• Kang YM, Kim Y-J, Park J-Y, et al. Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013. Cardiovasc Diabetol. 2016;15(1):131.
   PubMedGoogle Scholar
• Tseng CH. Mortality and causes of death in a national sample of diabetic patients in Taiwan. Diabetes Care. 2004;27(7):1605–1609.
   PubMed Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas. Diabetes Res Clin Pract. 9th, 2019;157:107843.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionNational Diabetes Statistics Report website [cited 2022 Apr 14]. Available from:: https://www.cdc.gov/diabetes/data/statistics-report/index.html
   Google Scholar
• Lin J, Thompson TJ, Cheng YJ, et al. Projection of the future diabetes burden in the United States through 2060. Popul Health Metr. 2018;16(1):9.
   PubMedGoogle Scholar
• Zhou JB, Tang X, Han M, et al. Impact of antidiabetic agents on dementia risk: a Bayesian network meta-analysis. Metabolism. 2020;109:154265.
   PubMed Web of Science ®Google Scholar
• Nichols E, Steinmetz JD, Vollset SE, et al. GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health. 2022;7(2):e105–e125.
   PubMed Web of Science ®Google Scholar
• O’Brien JT, Thomas A. Vascular dementia. Lancet. 2015;386(10004):1698–1706.
   PubMed Web of Science ®Google Scholar
• Ravona-Springer R, Davidson M, Noy S. Is the distinction between Alzheimer’s disease and vascular dementia possible and relevant? Dialogues Clin Neurosci. 2003 Mar;5(1):7–15.
   PubMedGoogle Scholar
• Chatterjee S, Mudher A. Alzheimer’s Disease and Type 2 Diabetes: a Critical Assessment of the Shared Pathological Traits. Front Neurosci. 2018;12:383.
   PubMed Web of Science ®Google Scholar
• Song J, Lee WT, Park KA, et al. Association between risk factors for vascular dementia and adiponectin. Biomed Res Int. 2014;2014:261672.
   PubMed Web of Science ®Google Scholar
• Tseng CH. Pioglitazone Reduces Dementia Risk in Patients with Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis. J Clin Med. 2018;7(10):306.
   PubMed Web of Science ®Google Scholar
• Tseng CH. Rosiglitazone has a neutral effect on the risk of dementia in type 2 diabetes patients. Aging (Albany NY). 2019;11(9):2724–2734.
   PubMedGoogle Scholar
• Jayaraj RL, Azimullah S, Beiram R. Diabetes as a risk factor for Alzheimer’s disease in the Middle East and its shared pathological mediators. Saudi J Biol Sci. 2020;27(2):736–750.
   PubMed Web of Science ®Google Scholar
• Kinney JW, Bemiller SM, Murtishaw AS, et al. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement (N Y). 2018;4:575–590.
   PubMedGoogle Scholar
• Herholz K, Haense C, Gerhard A, et al. Metabolic regional and network changes in Alzheimer’s disease subtypes. J Cereb Blood Flow Metab. 2018;38(10):1796–1806.
   PubMed Web of Science ®Google Scholar
• Karvani M, Simos P, Stavrakaki S, et al. Neurocognitive impairment in type 2 diabetes mellitus. Hormones (Athens). 2019;18(4):523–534.
   PubMedGoogle Scholar
• Secnik J, Xu H, Schwertner E, et al. The association of antidiabetic medications and Mini-Mental State Examination scores in patients with diabetes and dementia. Alzheimers Res Ther. 2021;13(1):197.
   PubMed Web of Science ®Google Scholar
• Mahikul W, White LJ, Poovorawan K, et al. A population dynamic model to assess the diabetes screening and reporting programs and project the burden of undiagnosed diabetes in Thailand. Int J Environ Res Public Health. 2019;16(12):2207.
   PubMed Web of Science ®Google Scholar
• Samaras K, Makkar S, Crawford JD, et al. Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: the Sydney Memory and Ageing Study. Diabetes Care. 2020;43(11):2691–2701.
   PubMed Web of Science ®Google Scholar
• Tseng CH. Dementia Risk in Type 2 Diabetes Patients: acarbose Use and Its Joint Effects with Metformin and Pioglitazone. Aging Dis. 2020;11(3):658–667.
   PubMed Web of Science ®Google Scholar
• Khattar D, Khaliq F, Vaney N, et al. Is Metformin-Induced Vitamin B12 Deficiency Responsible for Cognitive Decline in Type 2 Diabetes? Indian J Psychol Med. 2016;38(4):285–290.
   PubMedGoogle Scholar
• Alzheimer’s Society Vascular Dementia Systematic Review Group, Savva GM, Stephan BC. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke. 2010;41(1):e41–e46.
   PubMed Web of Science ®Google Scholar
• Weng ZB, Chen YR, Lv JT, et al. A review of bile acid metabolism and signaling in cognitive dysfunction-related diseases. Oxid Med Cell Longev. 2022;2022:4289383.
   PubMed Web of Science ®Google Scholar
• Wahlqvist ML, Lee MS, Hsu CC, et al. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson’s disease occurring with type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat Disord. 2012;18(6):753–758.
   PubMed Web of Science ®Google Scholar
• Son SM, Shin HJ, Byun J, et al. Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation. J Alzheimers Dis. 2016;51(4):1197–1208.
   PubMed Web of Science ®Google Scholar
• Imfeld P, Bodmer M, Jick SS, et al. Metformin, other antidiabetic drugs, and risk of Alzheimer’s disease: a population-based case-control study. J Am Geriatr Soc. 2012;60(5):916–921.
   PubMed Web of Science ®Google Scholar
• Tzeng IS. To handle the inflation of odds ratios in a retrospective study with a profile penalized log-likelihood approach. J Clin Lab Anal. 2021;35(7):e23849.
   PubMed Web of Science ®Google Scholar
• Jager KJ, Tripepi G, Chesnaye NC, et al. Where to look for the most frequent biases? Nephrology (Carlton). 2020;25(6):435–441.
   PubMed Web of Science ®Google Scholar